tirzépatide effets secondaires IC : le efficace dans l'IC à FE préservée avec obésité Tirzépatide : indications, prix, avis
Description
analysis [37], patients on GLP-1 RAs (exenatide, lixisenatide, semaglutide, dulaglutide, liraglutide, tirzepatide) had a significantly lower 1-year shunt placement rate (OR 0.375, 95% CI 0.1710.753, p = 0.047)
Sharps Disposal Containers
Pour qui
Clinical studies have found reductions in both systolic and diastolic blood pressure among patients taking tirzepatide, with much of the benefit occurring alongside significant weight loss
Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial
